<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2021.118543</article-id><article-id pub-id-type="publisher-id">ACM-44769</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20210800000_40540364.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  关于早期非小细胞肺癌手术方式选择研究进展
  Research Progress of Surgical Approach for Early Stage Non-Small Cell Lung Carcinoma
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>邵</surname><given-names>盛腾</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>衣</surname><given-names>腾飞</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>朱</surname><given-names>晗</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>秦</surname><given-names>坤</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>刘</surname><given-names>玉洪</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>青岛大学附属医院胸外科，山东 青岛</addr-line></aff><aff id="aff3"><addr-line>烟台毓璜顶医院耳鼻喉科，山东 烟台</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><aff id="aff4"><addr-line>青岛大学附属医院急诊科，山东 青岛</addr-line></aff><pub-date pub-type="epub"><day>02</day><month>08</month><year>2021</year></pub-date><volume>11</volume><issue>08</issue><fpage>3703</fpage><lpage>3708</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  肺癌是一种常见的肿瘤，在全球范围内有较高的发病率。近年来，随着检查技术的进步，早期非小细胞肺癌(non-small cell lung carcinoma, NSCLC)的发病率也随之上升。目前，手术切除仍然是早期NSCLC的首选治疗方法，手术方式主要包括：肺叶切除术，肺段切除术以及楔形切除术。本文主要探讨上述手术方式在早期非小细胞肺癌患者中的选择，来为早期NSCLC的治疗提供参考。
   Lung cancer is a common tumor with a high incidence worldwide. With the development of examination, the incidence of early-stage non-small cell lung carcinoma (NSCLC) is increasing recently. At present, surgical resection is still the preferred treatment for early stage NSCLC, the main surgical methods include lobectomy, segmentectomy and wedge resection. Therefore, this paper focuses on the choice of above approaches for patients with early-stage NSCLC so as to provide a reference for the treatment for early-stage NSCLC.
 
</p></abstract><kwd-group><kwd>非小细胞肺癌，手术方式，肺叶切除术，肺段切除术，楔形切除术, Non-Small Cell Lung Carcinoma</kwd><kwd> Surgical Approach</kwd><kwd> Lobectomy</kwd><kwd> Segmentectomy</kwd><kwd> Wedge Resection</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>肺癌是一种常见的肿瘤，在全球范围内有较高的发病率。近年来，随着检查技术的进步，早期非小细胞肺癌(non-small cell lung carcinoma, NSCLC)的发病率也随之上升。目前，手术切除仍然是早期NSCLC的首选治疗方法，手术方式主要包括：肺叶切除术，肺段切除术以及楔形切除术。本文主要探讨上述手术方式在早期非小细胞肺癌患者中的选择，来为早期NSCLC的治疗提供参考。</p></sec><sec id="s2"><title>关键词</title><p>非小细胞肺癌，手术方式，肺叶切除术，肺段切除术，楔形切除术</p></sec><sec id="s3"><title>Research Progress of Surgical Approach for Early Stage Non-Small Cell Lung Carcinoma<sup> </sup></title><p>Shengteng Shao<sup>1*</sup>, Tengfei Yi<sup>1</sup>, Han Zhu<sup>2</sup>, Kun Qin<sup>3</sup>, Yuhong Liu<sup>1#</sup></p><p><sup>1</sup>Department of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao Shandong</p><p><sup>2</sup>Department of Otolaryngology, Yantai Yuhuangding Hospital, Yantai Shandong</p><p><sup>3</sup>Department of Emergency, The Affiliated Hospital of Qingdao University, Qingdao Shandong</p><p><img src="//html.hanspub.org/file/60-1572498x5_hanspub.png?20210826083708000" /></p><p>Received: Jul. 23<sup>rd</sup>, 2021; accepted: Aug. 15<sup>th</sup>, 2021; published: Aug. 25<sup>th</sup>, 2021</p><p><img src="//html.hanspub.org/file/60-1572498x6_hanspub.png?20210826083708000" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>Lung cancer is a common tumor with a high incidence worldwide. With the development of examination, the incidence of early-stage non-small cell lung carcinoma (NSCLC) is increasing recently. At present, surgical resection is still the preferred treatment for early stage NSCLC, the main surgical methods include lobectomy, segmentectomy and wedge resection. Therefore, this paper focuses on the choice of above approaches for patients with early-stage NSCLC so as to provide a reference for the treatment for early-stage NSCLC.</p><p>Keywords:Non-Small Cell Lung Carcinoma, Surgical Approach, Lobectomy, Segmentectomy, Wedge Resection</p><disp-formula id="hanspub.44769-formula41"><graphic xlink:href="//html.hanspub.org/file/60-1572498x7_hanspub.png?20210826083708000"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2021 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/60-1572498x8_hanspub.png?20210826083708000" /> <img src="//html.hanspub.org/file/60-1572498x9_hanspub.png?20210826083708000" /></p></sec><sec id="s5"><title>1. 引言</title><p>肺癌的特点是早期转移和淋巴扩散，存活率低，是世界许多地区与恶性肿瘤相关死亡的主要原因。随着低剂量螺旋计算机断层扫描(LDCT)和高分辨率计算机断层扫描(HRCT)在肺癌筛查中的广泛使用，早期肺癌患者的数量也不断增加，这也意味着胸外科医生在临床实践中可能会遇到更多的小周围型肺癌 [<xref ref-type="bibr" rid="hanspub.44769-ref1">1</xref>]，在这些病灶中大约有10%被证实为非小细胞肺癌(non-small cell lung cancer, NSCLC) [<xref ref-type="bibr" rid="hanspub.44769-ref2">2</xref>]。虽然NSCLC的预后不甚乐观，但是IA期NSCLC的患者采取适当的手术治疗后5年生存率可高达70%，甚至有获得治愈机会 [<xref ref-type="bibr" rid="hanspub.44769-ref3">3</xref>]。</p><p>毫无疑问，手术切除仍然是早期NSCLC的首选治疗方法。曾经肺叶切除术是早期NSCLC的标准手术方式，据1995年北美肺癌研究小组研究结果显示，I期NSCLC的首选治疗方法是肺切除加根治性淋巴结清扫，与采用亚肺切除术相比，选择肺叶切除术的患者的生存率更高 [<xref ref-type="bibr" rid="hanspub.44769-ref4">4</xref>]。而且肺叶切除术被证明可以减少复发风险和优化长期生存的机会 [<xref ref-type="bibr" rid="hanspub.44769-ref5">5</xref>]。但是该研究包括不同临床阶段的患者并没有将亚肺切除术中的肺段切除术和楔形切除术分开来，因此结论受到一些专家的质疑。</p><p>近年来，随着相关临床试验结果的公布和关于这一主题的大量回顾性研究以及meta分析的开展，使我们对早期非小细胞肺癌标准手术方式的选择产生了疑惑，主要争论点在于是否选取亚肺叶切除术，包括肺段切除切除术和楔形切除术，其中肺段切除术，也可以称之为解剖性切除，是指切除一个解剖单位，通常还包括更大的淋巴结清扫范围，如果肺部的小结节在肺段切除之后，肿瘤预后方面类似于肺叶切除术，那么肺段切除术可能将会是他们首选的手术方式，因为它们切除的肺组织更少，从而可以更好地保存肺功能且不影响生存率，这一优势特别是在肺功能有限的患者或老年人中尤为显著 [<xref ref-type="bibr" rid="hanspub.44769-ref6">6</xref>]。而楔形切除术是指切除肺占位性病变部分，不考虑解剖边界的切除方式。</p></sec><sec id="s6"><title>2. 肺叶切除术与亚肺叶切除术</title><p>目前研究亚肺叶切除术与肺叶切除术的临床试验中，最早的一项是1995年发布的，Ginsberg等人认为与肺叶切除术相比，亚肺叶切除术并不能改善I期NSCLC术前的并发症、术后的死亡率或肺功能。而且由于亚肺叶切除术的死亡率和局部复发率较高。肺叶切除术仍然被认为是周围型T1N0非小细胞肺癌患者的首选手术方式 [<xref ref-type="bibr" rid="hanspub.44769-ref4">4</xref>]。</p><p>由国家癌症研究所(National Cancer Institute, NCI)于2008年开展的一项前瞻行研究CALGB140503，其主要目的是比较临床IA期的NSCLC在肺叶切除术和亚肺叶切除术术后的生存率。其结果发现在这些癌症患者中，术后的死亡率在肺叶和亚肺叶切除术之间几乎没有差别 [<xref ref-type="bibr" rid="hanspub.44769-ref7">7</xref>]。同样，在一项回顾性研究中筛选出肿瘤 &lt; 3 cm的，临床分期为IA的NSCLC患者，分别对行肺叶切除术和亚肺叶切除术的患者进行比较，发现两组患者术后生存率相当 [<xref ref-type="bibr" rid="hanspub.44769-ref8">8</xref>]。但是在另一项关于早期NSCLC的研究中发现，对于I期NSCLC的患者，亚肺叶切除术的生存率低于肺叶切除术，而肺段切除术的结果与肺叶切除术相当；然而对于肿瘤 ≤ 2 cm的IA期NSCLC患者，亚肺叶切除术与肺叶切除术有着相似的生存率 [<xref ref-type="bibr" rid="hanspub.44769-ref9">9</xref>]。</p><p>磨玻璃样外观可能是另一个决定治疗方式的重要因素。人们普遍认为，对于磨玻璃成分 ≥ 50%的结节预后较好，可以选择亚肺叶切除术 [<xref ref-type="bibr" rid="hanspub.44769-ref10">10</xref>] [<xref ref-type="bibr" rid="hanspub.44769-ref11">11</xref>]。但是对于影像学表现为实性的结节，患者的术后风险升高且亚肺叶切除术的效果可能不如肺叶切除术 [<xref ref-type="bibr" rid="hanspub.44769-ref12">12</xref>] [<xref ref-type="bibr" rid="hanspub.44769-ref13">13</xref>]，因此有观点认为肺叶切除术仍应是实体型、临床IA 期NSCLC的标准手术方式 [<xref ref-type="bibr" rid="hanspub.44769-ref14">14</xref>]。对于T1N0M0分期NSCLC的肺段切除术的术后效果可能受多种因素的影响，除了影像学表现，还有组织学亚型。据报道，亚肺叶切除术在原位癌或微浸润性腺癌可以取得较好的预后 [<xref ref-type="bibr" rid="hanspub.44769-ref15">15</xref>] [<xref ref-type="bibr" rid="hanspub.44769-ref16">16</xref>]。还有观点认为微乳头成分是重要的预后因素，在分析了734例来自纪念斯隆–凯特琳癌症中心腺癌患者的手术切下的肺组织与预后的关系后得出结论，当微乳头成分出现时，亚肺叶切除术的预后比肺叶切除术差5%甚至更高 [<xref ref-type="bibr" rid="hanspub.44769-ref17">17</xref>]。</p><p>近期一项研究发现虽然在IA期NSCLC患者中行肺叶切除术和亚肺叶切除术的术后5年生存率相似，但是亚肺叶组患者NSCLC的复发风险却增加了39%，同时发现接受肺叶切除术治疗的患者的中位淋巴结计数更高，并且得出结论亚肺叶切除与癌症复发风险增加39%相关。大多数接受亚肺叶切除术治疗的患者淋巴结评估并不充分，当把现有临床试验结果外推用于临床使用时，必须考虑真实世界的实际情况 [<xref ref-type="bibr" rid="hanspub.44769-ref18">18</xref>]。</p><p>值得一提的是，在老年(年龄 &gt; 65岁)的I期NSCLC患者中，亚肺叶切除术术后的生存率可能达到与肺叶切除术相似水平，考虑到亚肺叶切除术能更好地保留肺功能，特别是对于低FEV1百分比、呼吸功能储备降低的IA期且直径 &lt; 2 cm的老年NSCLC患者来说，可以优先选择亚非肺叶切除术作为其治疗方式 [<xref ref-type="bibr" rid="hanspub.44769-ref19">19</xref>]。但是要注意进行充分的淋巴结评估 [<xref ref-type="bibr" rid="hanspub.44769-ref20">20</xref>]。对于年轻(年龄 &lt; 35岁)的IA期NSCLC患者，亚肺叶切除术的术后效果并不差于肺叶切除术。考虑到亚肺叶切除术能更好地保留肺功能，亚肺叶切除术可能更适合治疗年轻的IA期NSCLC患者 [<xref ref-type="bibr" rid="hanspub.44769-ref21">21</xref>]。但是也有观点认为，对于体能状态良好或复发风险较高的患者，肺叶切除术依然是最安全和符合肿瘤学的选择。</p></sec><sec id="s7"><title>3. 肺叶切除术与肺段切除术和楔形切除术</title><p>西日本肿瘤学组和日本临床肿瘤学组于2009年开展一项3期临床试验(JCOG0802)结果表明，对于直径 ≤ 2 cm，CTR &gt; 0.5的浸润性周围型NSCLC患者，肺段切除术和肺叶切除术患者的术中和术后并发症的术后评估几乎没有差异，因此他们推荐肺段切除术应作为此类患者的标准手术方式，而不是肺叶切除术 [<xref ref-type="bibr" rid="hanspub.44769-ref22">22</xref>]。</p><p>早期NSCLC不仅仅局限于直径 ≤ 2 cm，CTR &gt; 0.5的浸润性周围型NSCLC。Keenan RJ等一项荟萃分析通过比较近年来相关文献指出在I期NSCLC中，肺段切除术的结果与肺叶切除术相当 [<xref ref-type="bibr" rid="hanspub.44769-ref6">6</xref>]。但是Zhang L的研究结果仍然支持肺叶切除术作为I期NSCLC的首选治疗方式，而且这项研究还显示对于IA期的NSCLC，肺段切除术后OS和LCSS相比于肺叶切除术更差，而RFS组间具有可比性 [<xref ref-type="bibr" rid="hanspub.44769-ref23">23</xref>]。另一项荟萃分析 [<xref ref-type="bibr" rid="hanspub.44769-ref24">24</xref>] 以及一项关于SEER数据库的分析 [<xref ref-type="bibr" rid="hanspub.44769-ref25">25</xref>] 的结果显示，对于IA期的NSCLC肺叶切除术优于肺段切除术，但在经过倾向评分匹配后，对于IA期&lt;2 cm的肿瘤，肺叶切除术和肺段切除术的患者术后效果并没有显著差异。但是其他数据库研究显示了不同的结果，对于&lt;2厘米的肿瘤，肺叶切除术具有优势 [<xref ref-type="bibr" rid="hanspub.44769-ref26">26</xref>]。</p><p>对于I期和IA期，肺叶切除术显示出相对较好的预后效果，而对于&lt;2 cm的肿瘤，我们的研究未发现两组之间的肿瘤学结果存在显着差异。这也表明，对于&lt;2 cm的NSCLC，肺段切除术可能是替代肺叶切除术的一种有价值治疗方法 [<xref ref-type="bibr" rid="hanspub.44769-ref27">27</xref>]。</p><p>最近一项基于SEER数据库的分析还调查了&lt;1 cm的NSCLC，肺段切除术很有希望成为其首选的手术方式 [<xref ref-type="bibr" rid="hanspub.44769-ref28">28</xref>]，肺段切除术后的五年总生存率和无病生存率与肺叶切除术的生存率相当 [<xref ref-type="bibr" rid="hanspub.44769-ref29">29</xref>]。其中，一项基于SEER数据库的研究结果表明对于2.1~3.0 cm的肿瘤，肺叶切除术仍然是标准的手术方式；但是对于不适合进行肺叶切除术的患者，肺段切除术和楔形切除术的存活率相似。对于1.1~2.0 cm的肿瘤，肺叶切除术和肺段切除术可导致相同的存活率，但显示出比楔形切除术观察到的更高的存活率。对于IA期NSCLC肺叶切除术、肺段切除术和楔形切除术对于≤1.0 cm的IA期NSCLC患者是可比较的肿瘤手术 [<xref ref-type="bibr" rid="hanspub.44769-ref30">30</xref>]。但是，有研究表明对于≤1 cm和1~2 cm的NSCLC患者肺叶切除术表现出更好的生存率。但是对于不适合进行肺叶切除术的患者，应推荐1~2 cm的NSCLC 进行肺段切除术，而对于≤1 cm的NSCLC，外科医生可以根据手术技术和患者情况决定肺段切除术和楔形切除术 [<xref ref-type="bibr" rid="hanspub.44769-ref31">31</xref>]。</p></sec><sec id="s8"><title>4. 肺段对比楔切</title><p>肺段切除术在OS和LCSS方面与楔形切除相比可以获得更好的结果 [<xref ref-type="bibr" rid="hanspub.44769-ref32">32</xref>]，肺段切除术是一种解剖学上的亚肺叶切除术，往往能比楔形切除术能取得更好的预后 [<xref ref-type="bibr" rid="hanspub.44769-ref33">33</xref>]。而且对于肿瘤≤2 cm或年龄&gt;70岁的患者，也获得了类似的结果 [<xref ref-type="bibr" rid="hanspub.44769-ref32">32</xref>]。目前普遍认为，肺段切除术的癌症控制优于楔形切除术。作为亚肺叶切除术，肺段切除术是治疗临床IA期非小细胞肺癌的首选肿瘤手术 [<xref ref-type="bibr" rid="hanspub.44769-ref34">34</xref>]。</p><p>对于计算机断层扫描诊断CTR ≤ 0.25且≤3个可接受亚肺叶切除的周围型小结节，西日本肿瘤学组和日本临床肿瘤学组发布的JCOG0804认为具有足够手术切缘的亚肺叶切除术为临床可切除的N0肺癌提供了足够的局部控制和无复发生存期，对GGO占主导的周围型肺癌进行亚肺叶切除是可行和有效的，如果合适的话可以进行解剖切除 [<xref ref-type="bibr" rid="hanspub.44769-ref35">35</xref>]。但是对于纯实体肿瘤，肺段切除术中评估淋巴结转移和足够的手术切缘可能是临床T1a-bN0M0肺癌可行的手术方法 [<xref ref-type="bibr" rid="hanspub.44769-ref36">36</xref>]。</p><p>对于肿瘤大小≤2 cm的IA期NSCLC，肺段切除术相较于楔形切除术可以获得更好的生存率。然而，对于≤1 cm的NSCLC，外科医生需要根据患者的情况和肿瘤的位置选择进行肺段切除术或者楔形切除术。这些结果应得到进一步随机临床试验的证实 [<xref ref-type="bibr" rid="hanspub.44769-ref37">37</xref>]。</p></sec><sec id="s9"><title>5. 总结与展望</title><p>对于早期NSCLC手术方式的选择，不仅需要考虑肿瘤的大小，淋巴结转移情况等，早期NSCLC的肺术后效果可能受多种因素的影响，比如电子计算机断层扫描中的实性成分占比，还有组织学亚型等。而且，目前的研究更关注于对&lt;2厘米的肿瘤的研究，较少单独提及2~3 cm肿瘤以及对其进行正式比较，因为它们通常在IA期的框架下被分析。随着研究的深入，保证切缘的楔形切除术是否能够替代部分肺段切除术也值得进一步探讨。</p></sec><sec id="s10"><title>文章引用</title><p>邵盛腾,衣腾飞,朱 晗,秦 坤,刘玉洪. 关于早期非小细胞肺癌手术方式选择研究进展Research Progress of Surgical Approach for Early Stage Non-Small Cell Lung Carcinoma[J]. 临床医学进展, 2021, 11(08): 3703-3708. https://doi.org/10.12677/ACM.2021.118543</p></sec><sec id="s11"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.44769-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Aberle, D.R., Adams, A.M., Berg, C.D., et al. (2011) Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. The New England Journal of Medicine, 365, 395-409. &lt;br&gt;https://doi.org/10.1056/NEJMoa1102873</mixed-citation></ref><ref id="hanspub.44769-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Kim, S.K., Allen-Auerbach, M., Goldin, J., et al. (2007) Accuracy of PET/CT in Characterization of Solitary Pulmonary Lesions. The Journal of Nuclear Medicine, 48, 214-20.</mixed-citation></ref><ref id="hanspub.44769-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Strand, T.E., Rostad, H., Moller, B. and Norstein, J. (2006) Survival after Resection for Primary Lung Cancer: A Population Based Study of 3211 Resected Patients. Thorax, 61, 710-715. &lt;br&gt;https://doi.org/10.1136/thx.2005.056481</mixed-citation></ref><ref id="hanspub.44769-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Ginsberg, R.J. and Rubinstein, L.V. (1995) Lung Cancer Study Group: Randomized Trial of Lobectomy versus Limited Resection for T1 N0 Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery, 60, 615-622. 
&lt;br&gt;https://doi.org/10.1016/0003-4975(95)00537-U</mixed-citation></ref><ref id="hanspub.44769-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Spira, A. and Ettinger, D.S. (2004) Multidisciplinary Management of Lung Cancer. The New England Journal of Medicine, 350, 379-92. &lt;br&gt;https://doi.org/10.1056/NEJMra035536</mixed-citation></ref><ref id="hanspub.44769-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Keenan, R.J., Landreneau, R.J., Maley, R.H., et al. (2004) Segmental Resection Spares Pulmonary Function in Patients with Stage I Lung Cancer. The Annals of Thoracic Surgery, 8, 228-233.  
&lt;br&gt;https://doi.org/10.1016/j.athoracsur.2004.01.024</mixed-citation></ref><ref id="hanspub.44769-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Altorki, N.K., Wang, X., Wigle, D., Gu, L., Darling, G., Ashrafi, A.S., Landrenau, R., Miller, D., Liberman, M., Jones, D.R., Keenan, R., Conti, M., Wright, G., Veit, L.J., Ramalingam, S.S., Kamel, M., Pass, H.I., Mitchell, J.D., Stinchcombe, T., Vokes, E. and Kohman, L.J. (2018) Perioperative Mortality and Morbidity after Sublobar versus Lobar Resection for Early-Stage Non-Small-Cell Lung Cancer: Post-Hoc Analysis of an International, Randomised, Phase 3 Trial (CALGB/Alliance 140503). The Lancet Respiratory Medicine, 6, 915-924.  
&lt;br&gt;https://doi.org/10.1016/S2213-2600(18)30411-9</mixed-citation></ref><ref id="hanspub.44769-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Altorki, N.K., Yip, R., Hanaoka, T., Bauer, T., Aye, R., Kohman, L., Sheppard, B., Thurer, R., Andaz, S., Smith, M., Mayfield, W., Grannis, F., Korst, R., Pass, H., Straznicka, M., Flores, R., Henschke, C.I. and I-ELCAP Investigators. (2014) Sublobar Resection Is Equivalent to Lobectomy for Clinical Stage 1A Lung Cancer in Solid Nodules. The Journal of Thoracic and Cardiovascular Surgery, 147, 754-762. &lt;br&gt;https://doi.org/10.1016/j.jtcvs.2013.09.065</mixed-citation></ref><ref id="hanspub.44769-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Fan, J., Wang, L., Jiang, G.N. and Gao, W. (2012) Sublobectomy versus Lobectomy for Stage I Non-Small-Cell Lung Cancer, a Meta-Analysis of Published Studies. Annals of Surgical Oncology, 19, 661-666. 
&lt;br&gt;https://doi.org/10.1245/s10434-011-1931-9</mixed-citation></ref><ref id="hanspub.44769-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Tsutani, Y., Miyata, Y., Nakayama, H., et al. (2014) Appropriate Sublobar Resection Choice for Ground Glass Opacitydominant Clinical Stage IA Lung Adenocarcinoma: Wedge Resection or Segmentectomy. Chest, 145, 66-71. 
&lt;br&gt;https://doi.org/10.1378/chest.13-1094</mixed-citation></ref><ref id="hanspub.44769-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Sim, H.J., Choi, S.H., Chae, E.J., et al. (2014) Surgical Management of Pulmonary Adenocarcinoma Presenting as a Pure Groundglass Nodule. European Journal of Cardio—Thoracic Surgery, 46, 632-636.  
&lt;br&gt;https://doi.org/10.1093/ejcts/ezu007</mixed-citation></ref><ref id="hanspub.44769-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Hattori, A., Matsunaga, T., Takamochi, K., et al. (2017) Locoregional Recurrence after Segmentectomy for Clinical-T1aN0M0 Radiologically Solid Non-Small-Cell Lung Carcinoma. European Journal of Cardio—Thoracic Surgery, 51, 518-525. &lt;br&gt;https://doi.org/10.1093/ejcts/ezw336</mixed-citation></ref><ref id="hanspub.44769-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Hattori, A., Suzuki, K., Matsunaga, T., et al. (2012) Is Limited Resection Appropriate for Radiologically “solid” Tumors in Small Lung Cancers? The Annals of Thoracic Surgery, 94, 212-215.  
&lt;br&gt;https://doi.org/10.1016/j.athoracsur.2012.03.033</mixed-citation></ref><ref id="hanspub.44769-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Jeon, H.W., Kim, Y.D., Kim, K.S., Sung, S.W., Park, H.J. and Park, J.K. (2014) Sublobar Resection versus Lobectomy in Solid-Type, Clinical Stage IA, Non-Small Cell Lung Cancer. World Journal of Surgical Oncology, 12, Article No. 215. &lt;br&gt;https://doi.org/10.1186/1477-7819-12-215</mixed-citation></ref><ref id="hanspub.44769-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Sagawa, M., Oizumi, H., Suzuki, H., et al. (2018) A Prospective 5-Year Follow-Up Study after Limited Resection for Lung Cancer with Ground-Glass Opacity. European Journal of Cardio—Thoracic Surgery, 53, 849-856. 
&lt;br&gt;https://doi.org/10.1093/ejcts/ezx418</mixed-citation></ref><ref id="hanspub.44769-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Liu, S., Wang, R., Zhang, Y., et al. (2016) Precise Diagnosis of Intraoperative Frozen Section Is an Effective Method to Guide Resection Strategy for Peripheral Small-Sized Lung Adenocarcinoma. Journal of Clinical Oncology, 34, 307-313. &lt;br&gt;https://doi.org/10.1200/JCO.2015.63.4907</mixed-citation></ref><ref id="hanspub.44769-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Nitadori, J., Bograd, A.J., Kadota, K., et al. (2013) Impact of Micropapillary Histologic Subtype in Selecting Limited Resection vs Lobectomy for Lung Adenocarcinoma of 2 cm or Smaller. Journal of the National Cancer Institute, 105, 1212-1220. &lt;br&gt;https://doi.org/10.1093/jnci/djt166</mixed-citation></ref><ref id="hanspub.44769-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Subramanian, M., McMurry, T., Meyers, B.F., Puri, V. and Kozower, B.D. (2018) Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection. Annals of Thoracic Surgery, 106, 375-381. 
&lt;br&gt;https://doi.org/10.1016/j.athoracsur.2018.02.049</mixed-citation></ref><ref id="hanspub.44769-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Qiu, C., Wang, G., Xu, J., Cui, L., Dong, W., Ni, Y., Qu, X. and Du, J. (2017) Sublobectomy versus Lobectomy for Stage I Non-Small Cell Lung Cancer in the Elderly. International Journal of Surgery, 37, 1-7. 
&lt;br&gt;https://doi.org/10.1016/j.ijsu.2016.11.090</mixed-citation></ref><ref id="hanspub.44769-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, B., Liu, R., Ren, D., Li, X., Wang, Y., Huo, H., Zhu, S., Chen, J., Song, Z. and Xu, S. (2021) Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching’s Study. Frontiers in Oncology, 11, Article ID: 610638. &lt;br&gt;https://doi.org/10.3389/fonc.2021.610638</mixed-citation></ref><ref id="hanspub.44769-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Gu, C., Wang, R., Pan, X., Huang, Q., Zhang, Y., Yang, J. and Shi, J. (2017) Sublobar Resection versus Lobectomy in Patients Aged ≤35 Years with Stage IA Non-Small Cell Lung Cancer: A SEER Database Analysis. Journal of Cancer Research and Clinical Oncology, 143, 2375-2382. &lt;br&gt;https://doi.org/10.1007/s00432-017-2499-y</mixed-citation></ref><ref id="hanspub.44769-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Suzuki, K., Saji, H., Aokage, K., Watanabe, S.I., Okada, M., Mizusawa, J., Nakajima, R., Tsuboi, M., Nakamura, S., Nakamura, K., Mitsudomi, T., Asamura, H., West Japan Oncology Group and Japan Clinical Oncology Group (2019) Comparison of Pulmonary Segmentectomy and Lobectomy: Safety Results of a Randomized Trial. The Journal of Thoracic and Cardiovascular Surgery, 158, 895-907. &lt;br&gt;https://doi.org/10.1016/j.jtcvs.2019.03.090</mixed-citation></ref><ref id="hanspub.44769-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, L., Li, M., Yin, R., Zhang, Q. and Xu, L. (2015) Comparison of the Oncologic Outcomes of Anatomic Segmentectomy and Lobectomy for Early-Stage Nonsmall Cell Lung Cancer. The Annals of Thoracic Surgery, 99, 728-737. &lt;br&gt;https://doi.org/10.1016/j.athoracsur.2014.08.080</mixed-citation></ref><ref id="hanspub.44769-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Bao, F., Ye, P., Yang, Y., Wang, L., Zhang, C., Lv, X., et al. (2014) Segmentectomy or Lobectomy for Early Stage Lung Cancer: A Meta-Analysis. European Journal of Cardio—Thoracic Surgery, 46, 1-7. 
&lt;br&gt;https://doi.org/10.1093/ejcts/ezt554</mixed-citation></ref><ref id="hanspub.44769-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, Y., Yuan, C., Zhang, Y., Sun, Y. and Chen, H. (2016) Survival Following Segmentectomy or Lobectomy in Elderly Patients with Early-Stage Lung Cancer. Oncotarget, 7, 1-6. &lt;br&gt;https://doi.org/10.18632/oncotarget.7704</mixed-citation></ref><ref id="hanspub.44769-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Khullar, O.V., Liu, Y., Gillespie, T., Higgins, K.A., Ramalingam, S., Lipscomb, J. and Fernandez, F.G. (2015) Survival after Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer: An Analysis from the National Cancer Data Base. Journal of Thoracic Oncology, 10, 1625-1633. &lt;br&gt;https://doi.org/10.1097/JTO.0000000000000664</mixed-citation></ref><ref id="hanspub.44769-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Winckelmans, T., Decaluwé, H., De Leyn, P. and Van Raemdonck, D. (2020) Segmentectomy or Lobectomy for Early-Stage Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. European Journal of Cardio—Thoracic Surgery, 57, 1051-1060. &lt;br&gt;https://doi.org/10.1093/ejcts/ezz339</mixed-citation></ref><ref id="hanspub.44769-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Qu, X., Wang, K., Zhang, T., Shen, H., Dong, W., Liu, Q. and Du, J. (2017) Long-Term Outcomes of Stage I NSCLC (≤3 cm) Patients Following Segmentectomy Are Equivalent to Lobectomy under Analogous Extent of Lymph Node Removal: A PSM Based Analysis. Journal of Thoracic Disease, 9, 4561-4573.  
&lt;br&gt;https://doi.org/10.21037/jtd.2017.10.129</mixed-citation></ref><ref id="hanspub.44769-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Ijsseldijk, M.A., Shoni, M., Siegert, C., Seegers, J., van Engelenburg, A.K.C., Tsai, T.C., Lebenthal, A. and Ten Broek, R.P.G. (2020) Oncological Outcomes of Lobar Resection, Segmentectomy, and Wedge Resection for T1a Non-Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis. Seminars in Thoracic and Cardiovascular Surgery, 32, 582-590. &lt;br&gt;https://doi.org/10.1053/j.semtcvs.2019.08.004</mixed-citation></ref><ref id="hanspub.44769-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Cao, J., Yuan, P., Wang, Y., Xu, J., Yuan, X., Wang, Z., Lv, W. and Hu, J. (2018) Survival Rates after Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery, 105, 1483-1491. &lt;br&gt;https://doi.org/10.1016/j.athoracsur.2018.01.032</mixed-citation></ref><ref id="hanspub.44769-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Dai, C., Shen, J., Ren, Y., Zhong, S., Zheng, H., He, J., Xie, D., Fei, K., Liang, W., Jiang, G., Yang, P., Petersen, R.H., Ng, C.S., Liu, C.C., Rocco, G., Brunelli, A., Shen, Y., Chen, C. and He, J. (2016) Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or &gt; 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study. Journal of Clinical Oncology, 34, 3175-3182. 
&lt;br&gt;https://doi.org/10.1200/JCO.2015.64.6729</mixed-citation></ref><ref id="hanspub.44769-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Smith, C.B., Swanson, S.J., Mhango, G. and Wisnivesky, J.P. (2013) Survival after Segmentectomy and Wedge Resection in Stage I Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology, 8, 73-78. 
&lt;br&gt;https://doi.org/10.1097/JTO.0b013e31827451c4</mixed-citation></ref><ref id="hanspub.44769-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Hou, B., Deng, X.F., Zhou, D., et al. (2016) Segmentectomy versus Wedge Resection for the Treatment of High-Risk Operable Patients with Stage I Non-Small Cell Lung Cancer: A Metaanalysis. Therapeutic Advances in Respiratory Disease, 10, 435-443. &lt;br&gt;https://doi.org/10.1177/1753465816667121</mixed-citation></ref><ref id="hanspub.44769-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Tsutani, Y., Handa, Y., Shimada, Y., Ito, H., Ikeda, N., Nakayama, H., Yoshimura, K. and Okada, M. (2020) Comparison of Cancer Control between Segmentectomy and Wedge Resection in Patients with Clinical Stage IA Non-Small Cell Lung Cancer. The Journal of Thoracic and Cardiovascular Surgery, 20, 32833-32836. 
&lt;br&gt;https://doi.org/10.1016/j.jtcvs.2020.10.024</mixed-citation></ref><ref id="hanspub.44769-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Suzuki, K., Watanabe, S.I., Wakabayashi, M., Saji, H., Aokage, K., Moriya, Y., Yoshino, I., Tsuboi, M., Nakamura, S., Nakamura, K., Mitsudomi, T., Asamura, H. and West Japan Oncology Group and Japan Clinical Oncology Group (2020) A Single-Arm Study of Sublobar Resection for Ground-Glass Opacity Dominant Peripheral Lung Cancer. The Journal of Thoracic and Cardiovascular Surgery, 20, 33043-33049. &lt;br&gt;https://doi.org/10.1016/j.jtcvs.2020.09.146</mixed-citation></ref><ref id="hanspub.44769-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Tsubokawa, N., Tsutani, Y., Miyata, Y., Handa, Y., Misumi, K., Hanaki, H., Hida, E. and Okada, M. (2018) Segmentectomy versus Lobectomy for Radiologically Pure Solid Clinical T1a-bN0M0 Lung Cancer. World Journal of Surgery, 42, 2493-2501. &lt;br&gt;https://doi.org/10.1007/s00268-018-4514-0</mixed-citation></ref><ref id="hanspub.44769-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Xue, W., Duan, G., Zhang, X., Zhang, H., Zhao, Q. and Xin, Z. (2018) Meta-Analysis of Segmentectomy versus Wedge Resection in Stage IA Non-Small-Cell Lung Cancer. OncoTargets and Therapy, 11, 3369-3375. 
&lt;br&gt;https://doi.org/10.2147/OTT.S161367</mixed-citation></ref></ref-list></back></article>